Patient safety top of FDA’s new regulatory priorities

The FDA’s strategic planning to 2018 is taking a targeted focus: patient safety, according to the agency’s newly released priorities report.

Advertisement

Of the organization’s operational goals for the next four years, 75 percent are dedicated to patient-safety related objectives. They include:

  • Enhance oversight of FDA-regulated products
  • Improve and safeguard access to FDA-regulated products to benefit health
  • Promote better informed decisions about the use of FDA-regulate products

To accomplish these goals, the FDA plans to review the ways in which it leverages its analytics capabilities, according to a report from HealthIT Analytics.

More articles on accreditation:
AAAHC to host infection prevention session
Top 10 sentinel events for the first half of 2014
4 steps to a culture of communication

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Accreditation, Licensure & Medicare Certification

Advertisement

Comments are closed.